Pharmaceutical Industry Going Through Intense TherapyBy Mónica López | Tue, 02/16/2021 - 09:40
You can read our editorial coverage of this panel here.
The pandemic gave the pharmaceutical industry a window of opportunity to prove its worth, agreed panelists on Day 1 of Mexico Health Summit. Despite the challenges, the efforts to develop a vaccine in record time allowed the industry to demonstrate its value, stated Arturo de la Rosa, General Manager of AbbVie Mexico. One of these challenges, said Juan Luis Serrano, Life Sciences and Intellectual Property Partner at Sánchez Devanny, is the delays in approval of molecules and government authorizations that have been put on hold due to the pandemic for no good reason. Everything involving this industry should be considered an essential activity,” he said. Karel Fucikovsky, Pharma Director at Pierre Fabre Mexico, added that if authorities do not take action in time, the Mexican health system will lose the opportunity to improve.